Global Cold Pain Therapy Market size, share, Growth & Trends Analysis Report by Products (OTC Products and Prescription Products) by Application(Musculoskeletal Disorders, Post-Operative Therapy, Sports Medicine and Post-Trauma Therapy) and Region-Market Intelligence and Forecast, 2019-2025.
Date: Jun-2019 | Id: MACRC-0016 | Geographical Scope: Global | Publisher: MACRC
“Global Cold Pain Therapy Market was valued at USD 1.50 Billion in the year 2017 and is expected to reach approximately USD 2.12 Billion by 2025, at CAGR 4.4% from 2019 to 2025.”
Introduction
Cold pain therapy is used to reduce swelling and inflammation, muscle spasm and pain. It is also called cryotherapy and reduces the nerve activity for some time which decreases the pain. Thus, cold pain therapy is the most effective and cheap method to relieve pain and swelling by using ice packs. Application of ice packs to skin o relieves strains, bruises, and tendinitis or any virtual situation on superficial tissues. Cold Pain therapy is majorly applied for fresh injuries such as muscle sprains, ligament sprains, and severe bruises. Cold packs act as the primary analgesic to relieve pain. Cold pain therapy is also helpful for chronic overuse or tissue fatigue injuries like carpal tunnel syndrome, iliotibial band syndrome, tennis elbow, supraspinatus tendinitis, patellofemoral pain syndrome, and plantar fasciitis.
The Cold Pain Therapy market is divided on the basis of products, application, and region. By product, the market is fragmented into over the counter (OTC) product and prescription product. OTC products are further segmented into pharmaceuticals and medical devices. Prescription products are sub-segmented into motorized devices and non-motorized devices. OTC products are expected to grow with the highest CAGR due to the high preference of patient for topical pharmaceuticals, lower side effects fast pain relief and convenience. Application-wise, the cold chain therapy market is classified into post-operative therapy, musculoskeletal disorders, sports medicine, and post-trauma therapy.
Market Dynamics
Major factors which driving the growth of the market are growing number of injury cases caused by sports activities, gym activates, and growth in health care expenditure. However, side effects and discomfort related to the treatment are restraining the cold chain therapy market. In addition, lack of compensation and clinical indication are hampering the market growth. Nonetheless, the inflexible regulatory approval process for oral pain medicines and growing awareness among consumers will proliferate the demand for cold chain therapy market during the forecast period.
Geographical Outlook
The global cold pain therapy market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America has dominated the cold pain therapy market share in terms of revenue due to the high usage of these products in this region. Europe region is followed by North America owing to increased emphasis on maintenance of physical health with exercise and healthcare services. The Asia Pacific is a lucrative market for cold pain therapy in the coming years as many small players are looking forward to investment in the Asia Pacific market. The Middle East and Africa are emerging markets for cold pain therapy due to low investment in the healthcare services however, healthcare facilities and awareness are improving in these regions.
Market Segmentation
On the Basis of Product
Key Players
Some of the key players operating in the global cold pain therapy market are Beiersdorf, Ossur, Performance Health, Pfizer, Hisamitsu Pharmaceutical, Johnson & Johnson, Breg, Sanofi, DJO Finance, Medline Industries, and others.
Key questions addressed by the report:
Introduction
Cold pain therapy is used to reduce swelling and inflammation, muscle spasm and pain. It is also called cryotherapy and reduces the nerve activity for some time which decreases the pain. Thus, cold pain therapy is the most effective and cheap method to relieve pain and swelling by using ice packs. Application of ice packs to skin o relieves strains, bruises, and tendinitis or any virtual situation on superficial tissues. Cold Pain therapy is majorly applied for fresh injuries such as muscle sprains, ligament sprains, and severe bruises. Cold packs act as the primary analgesic to relieve pain. Cold pain therapy is also helpful for chronic overuse or tissue fatigue injuries like carpal tunnel syndrome, iliotibial band syndrome, tennis elbow, supraspinatus tendinitis, patellofemoral pain syndrome, and plantar fasciitis.
The Cold Pain Therapy market is divided on the basis of products, application, and region. By product, the market is fragmented into over the counter (OTC) product and prescription product. OTC products are further segmented into pharmaceuticals and medical devices. Prescription products are sub-segmented into motorized devices and non-motorized devices. OTC products are expected to grow with the highest CAGR due to the high preference of patient for topical pharmaceuticals, lower side effects fast pain relief and convenience. Application-wise, the cold chain therapy market is classified into post-operative therapy, musculoskeletal disorders, sports medicine, and post-trauma therapy.
Market Dynamics
Major factors which driving the growth of the market are growing number of injury cases caused by sports activities, gym activates, and growth in health care expenditure. However, side effects and discomfort related to the treatment are restraining the cold chain therapy market. In addition, lack of compensation and clinical indication are hampering the market growth. Nonetheless, the inflexible regulatory approval process for oral pain medicines and growing awareness among consumers will proliferate the demand for cold chain therapy market during the forecast period.
Geographical Outlook
The global cold pain therapy market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America has dominated the cold pain therapy market share in terms of revenue due to the high usage of these products in this region. Europe region is followed by North America owing to increased emphasis on maintenance of physical health with exercise and healthcare services. The Asia Pacific is a lucrative market for cold pain therapy in the coming years as many small players are looking forward to investment in the Asia Pacific market. The Middle East and Africa are emerging markets for cold pain therapy due to low investment in the healthcare services however, healthcare facilities and awareness are improving in these regions.
Market Segmentation
On the Basis of Product
- OTC Products
- Pharmaceuticals
- Medical Devices
- Prescription Products
- Motorized Devices
- Non-Motorized Devices
- Musculoskeletal Disorders
- Post-Operative Therapy
- Sports Medicine
- Post-Trauma Therapy
- North America
- Europe
- Asia-Pacific
- RoW
Key Players
Some of the key players operating in the global cold pain therapy market are Beiersdorf, Ossur, Performance Health, Pfizer, Hisamitsu Pharmaceutical, Johnson & Johnson, Breg, Sanofi, DJO Finance, Medline Industries, and others.
Key questions addressed by the report:
- What are the key trends and dynamics existing in the market?
- What are the global opportunities in the cold pain therapy market?
- Who are the major market players in the cold pain therapy market?
- How competitive is the market?
- What are the growth trends and the largest revenue-generating region for cold pain therapy market?
- What are the emerging trends?
- Which geographical region is holding major potential for new entrants?
Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions 1.3. List of Data Sources 1.4. List of Abbreviations Chapter 2. Executive Summary 2.1. Cold Pain Therapy Market - Industry Snapshot 2.2. Cold Pain Therapy Market Chapter 3. Customer Care BPO Industry Outlook 3.1. Market Segmentation 3.2. Value Chain Analysis 3.3. Market Dynamics 3.3.1. Market driver analysis 3.3.2. Market restraint analysis 3.3.3. Market opportunity analysis 3.4. Penetration & Growth Prospects Mapping 3.5. Industry Analysis - Porter’s Five Forces Analysis 3.6. PESTEL Analysis Chapter 4. Cold Pain Therapy Market: By Type(USD Billion) 4.1. OTC Products 4.2. Prescription Product Chapter 5. Cold Pain Therapy Market: Application (USD Billion) 5.1 Musculoskeletal Disorders 5.2 Post-Operative Therapy 5.3 Sports Medicine 5.4 Post-Trauma Therapy Chapter 6. Cold Pain Therapy Market: Regional Outlook 6.1. Cold Pain Therapy Market Estimates & Forecasts 6.2. North America 6.2.1. Market estimates and forecasts 6.2.2. Market estimates and forecasts, By Product 6.2.3. Market estimates and forecasts, By Application 6.2.4. U.S. 6.2.4.1. Market estimates and forecasts 6.2.4.2. Market estimates and forecasts, By Product 6.2.4.3. Market estimates and forecasts, By Application 6.2.5. Canada 6.2.5.1. Market estimates and forecasts 6.2.5.2. Market estimates and forecasts, By Product 6.2.5.3. Market estimates and forecasts, By Application 6.3. Europe 6.3.1. Market estimates and forecasts 6.3.2. Market estimates and forecasts, By Product 6.3.3. Market estimates and forecasts, By Application 6.3.4. U.K. 6.3.4.1. Market estimates and forecasts 6.3.4.2. Market estimates and forecasts, By Product 6.3.4.3. Market estimates and forecasts, By Application 6.3.5. Germany 6.3.5.1. Market estimates and forecasts 6.3.5.2. Market estimates and forecasts, By Product 6.3.5.3. Market estimates and forecasts, By Application 6.3.6. France 6.3.6.1. Market estimates and forecasts 6.3.6.2. Market estimates and forecasts, By Product 6.3.6.3. Market estimates and forecasts, By Application 6.4. Asia Pacific 6.4.1. Market estimates and forecasts 6.4.2. Market estimates and forecasts, By Product 6.4.3. Market estimates and forecasts, By Application 6.4.4. China 6.4.4.1. Market estimates and forecasts 6.4.4.2. Market estimates and forecasts, By Product 6.4.4.3. Market estimates and forecasts, By Application 6.4.5. India 6.4.5.1. Market estimates and forecasts 6.4.5.2. Market estimates and forecasts, By Product 6.4.5.3. Market estimates and forecasts, By Application 6.4.6. Japan 6.4.6.1. Market estimates and forecasts 6.4.6.2. Market estimates and forecasts, By Product 6.4.6.3. Market estimates and forecasts, By Application 6.4.7. Singapore 6.4.7.1. Market estimates and forecasts 6.4.7.2. Market estimates and forecasts, By Product 6.4.7.3. Market estimates and forecasts, By Application 6.5. Latin America 6.5.1. Market estimates and forecasts 6.5.2. Market estimates and forecasts, By Product 6.5.3. Market estimates and forecasts, By Application 6.5.4. Brazil 6.5.4.1. Market estimates and forecasts 6.5.4.2. Market estimates and forecasts, By Product 6.5.4.3. Market estimates and forecasts, By Application 6.5.5. Mexico 6.5.5.1. Market estimates and forecasts 6.5.5.2. Market estimates and forecasts, By Product 6.5.5.3. Market estimates and forecasts, By Application 6.6. Middle East & Africa 6.6.1. Market estimates and forecasts 6.6.2. Market estimates and forecasts, By Product 6.6.3. Market estimates and forecasts, By Application Chapter 7. Competitive Landscape 7.1 Beiersdorf 7.1.1. Company overview 7.1.2. Financial performance 7.1.3. Product benchmarking 7.1.4. Recent developments 7.2. Ossur 7.2.1. Company overview 7.2.2. Financial performance 7.2.3. Product benchmarking 7.2.4. Recent developments 7.3. Performance Health 7.3.1. Company overview 7.3.2. Financial performance 7.3.3. Product benchmarking 7.3.4. Recent developments 7.4. Pfizer 7.4.1. Company overview 7.4.2. Financial performance 7.4.3. Product benchmarking 7.4.4. Recent developments 7.5. Hisamitsu Pharmaceutical 7.5.1. Company overview 7.5.2. Financial performance 7.5.3. Product benchmarking 7.5.4. Recent developments 7.6. Johnson & Johnson 7.6.1. Company overview 7.6.2. Financial performance 7.6.3. Product benchmarking 7.6.4. Recent developments 7.7. Breg 7.7.1. Company overview 7.7.2. Financial performance 7.7.3. Product benchmarking 7.7.4. Recent developments 7.8. Sanofi 7.8.1. Company overview 7.8.2. Financial performance 7.8.3. Product benchmarking 7.8.4. Recent developments 7.9. DJO Finance 7.9.1. Company overview 7.9.2. Financial performance 7.9.3. Product benchmarking 7.9.4. Recent developments 7.10. Medline Industries 7.10.1. Company overview 7.10.2. Financial performance 7.10.3. Product benchmarking 7.10.4. Recent developments
Related reports
Non-Hodgkin Lymphoma Therapeutics Market
$2000-$6000
Acrylic Teeth Market
$3600-$7000